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The multifactorial pathogenesis of autoimmune disease has
been widely confirmed; indeed, several evidences underline
the interaction between genetic and environmental factors
in determining the development of autoimmunity [1]. The
higher concordance ratio between monozygotic twins com-
pared to dizygotic twins or other siblings confirmed the role
of genetic factors in the pathogenesis of many autoimmune
diseases.More recently, genomewide association studies have
allowed the identification of several genetic loci associated
not only with disease susceptibility, but also with specific
clinical manifestations or outcomes [1].The proteins encoded
by genes associatedwith autoimmune diseases are involved in
several inflammatory mechanisms, such as antigen presenta-
tion, type I interferon, Toll-like receptor andNF-𝜅B signaling,
B-cell and T-cell function, apoptosis, and clearance of cellular
debris and immune complexes [2]. Genetic variants could
induce proteins modifications, in terms of production rate
and function, with possible changes in the related processes.
Moreover, different autoimmune diseases are linked with the
same geneticmodifications, suggesting a shared genetic path-
way to loss of tolerance and induction of autoimmunity [1, 2].
The present special issue includes 2 reviews and 12
research articles, focusing on aspects related to genetic factors
in determining autoimmune diseases susceptibility and phe-
notype. Interestingly, in addition to classical autoimmune
diseases, such as Systemic Lupus Erythematosus (SLE) and
Sjo¨gren’s Syndrome (SjS), others have been investigated,
making this special issue evenmore intriguing. Looking at the
broad spectrum of genetics and autoimmunity, the role of
HLA-DRB1 alleles has been evaluated in a large cohort of
patients affected by different autoimmune diseases, identify-
ing associations between specific alleles and different diseases
and the HLA-DRB13 underrepresentation in all diseases
evaluated [e.g., SLE, Psoriasis (PS), Psoriatic Arthritis (PsA),
Rheumatoid Arthritis (RA), Systemic Sclerosis (SSc), Mul-
tiple Sclerosis (MS), and Myasthenia Gravis (MG)]. A very
recent paper has confirmed such role of the HLA-DRB1∗13
showing that some alleles are associated with protection from
ACPA-positive RA, but not with significant protection from
ACPA in individuals without RA. These data indicate that
HLA-DRB1∗13 mainly affects the onset of ACPA-positive RA
in ACPA positive non-RA individuals [3].
Moreover, the special issue includes an interesting evalu-
ation of familial aggregation of first-degree relatives as well as
segregation analysis in families presenting with autoimmune
diseases. Polyautoimmunity and multiple autoimmune syn-
drome seem to be dependent traits, while gender, age, and age
of onset are interrelated factors that also influence autoim-
munity.
Five studies addressed the role of genetic factors in SLE
susceptibility and phenotypes. In particular, the association
between the polymorphisms of the gamma-aminobutyric acid
receptor subunit pi (GABRP) gene, neurological diseases, and
SLE susceptibility has been investigated, revealing signifi-
cant differences in terms of genotype frequencies (rs929763,
rs732157, and rs3805455) among SLE patients compared with
the control group. The first evidence for the role of cyclic
AMP-responsive element modulator 𝛼 (CREM𝛼) polymor-
phisms in SLE susceptibility has been suggested in this
issue. CREM proteins are members of the leucine zipper
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protein superfamily of nuclear transcription factors and act
as regulators of cAMP-mediated signal transduction.Moving
from the evidence demonstrating CREM𝛼 overexpression in
T cells from SLE patients, specific CREM𝛼 SNPs (rs2295415,
rs1057108) seem to be associated with SLE susceptibility.
Genetic factors are associated not only with SLE sus-
ceptibility, but also with specific disease phenotypes: data
published so far deriving from the analysis of small cohorts,
which did not enable conclusive results. Remarkably, the
majority of studies published so far on this linkage focused
on the influence of genetic factors in determining renal
manifestations. In this special issue, a relationship between
ATG5 SNPs and lupus nephritis has been suggested, by using
new systemic genetics approach.
Moreover, the expansion of CD25high FoxP3high B regu-
latory cells in SLE patients is an intriguing topic. This cell
subset, characterized by high expression of IL-10, was found
to be increased in SLE patients and in correlationwith disease
activity. This result suggests that these cells expansion could
represent the attempt of the regulatory immune responses to
maintain self-tolerance and to suppress SLE disease activity.
Other systemic and organ specific autoimmune diseases have
also been linked to genetic factors. In SjS and SjS-related
lymphomagenesis, Sjo¨gren’s disease was linked with genetic
variants in the major histocompatibility complex (MHC)
locus. Moreover, genetic variants outside the MHC locus,
such as those involving genes of the type I interferon pathway,
NF-𝜅B signaling, B-cell and T-cell function, and methylation
processes, have also been described.
Two further studies evaluated pediatric autoimmune
disease, such as juvenile idiopathic arthritis (JIA) and autoim-
mune hepatitis (AIH). An association between poor prog-
nosis in JIA patients and the TRAF1/C5 gene locus was
suggested, although larger studies are required to confirm
this result. Furthermore, the role of IL-13, IL-4RA, and HLA-
DRB1 polymorphisms in AIH type I has been evaluated,
identifying an association with specific genetic variants.
In another liver disease, Primary Sclerosing Cholangitis
(PSC), the expression of sulfotransferase 2A1 (SULT2A1)
enzyme has been estimated, founding a modification of
SULT2A1 expression, probably related to the impaired hep-
atoprotection.Moreover, miRNA analysis suggested a role for
miR-378a-5p in the SULT2A1 expression.
A large number of SNPs in genes previously associated
with skin autoimmune disease plaque psoriasis (PS) have
been investigated in a large population. The distinction
between type I (early-onset, <40 years) and type II (late-
onset, ≥40 years) PS reveals an association between early-
onset and polymorphisms of the CLMN, FBXL19, CCL4L,
C17orf51, TYK2, IL-13, SLC22A4, CDKAL1, and HLA-
B/MICA genes. Moreover, a significant association between
age at onset and gene variants of PSORS6, TNF-𝛼, FCGR2A,
TNFR1, CD226, HLA-C, TNFAIP3, and CCHCR1 was also
identified. These data suggested the role of genetic factors in
determining the age of onset in patients with plaque psoriasis.
Another organ specific autoimmune disease, uveitis, has
been investigated for the interaction between disease and IL-
6 gene polymorphism and HLA-B27. A significantly higher
frequency of the minor allele for rs1800795 in patients with
intermediate uveitis compared to controls has been identified,
suggesting a role of IL-6 as therapeutic target in patients with
HLA-B27 associated uveitis. Last but not least, a study on 235
hemochromatosis probands was performed, demonstrating
the presence of autoimmune conditions in high percentage of
subjects, with Hashimoto’s thyroiditis being most prevalent.
Notably, the risk of autoimmunity in this scenario was not
associated with any HLA haplotype.
In conclusion, the present special issue adds interesting
data concerning genetic factors associated with different sys-
temic and organ specific autoimmune diseases, evaluating the
genetic impact both on disease susceptibility and on disease
phenotypes. Conspicuously, there is an urgent need for more
studies utilizing large cohorts that will broaden our knowl-
edge as currently it is estimated that only about 15% of the
genetic factors contributing to autoimmune disease suscep-
tibility have been identified [4]. Moreover, besides genetic
association studies, functional analyses aiming at unveiling
the mechanistic role of each factor should be performed.
Novel techniques, including next-generation sequencing
studies, will further contribute and expand our understand-
ing of the genetic basis of autoimmunity.
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